Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-010035
Filing Date
2022-04-15
Accepted
2022-04-15 12:26:27
Documents
78
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2045507
2 ex31-1.htm EX-31.1 21124
3 ex32-1.htm EX-32.1 8011
  Complete submission text file 0001493152-22-010035.txt   10164799

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nphc-20211231.xsd EX-101.SCH 64476
5 XBRL CALCULATION FILE nphc-20211231_cal.xml EX-101.CAL 76159
6 XBRL DEFINITION FILE nphc-20211231_def.xml EX-101.DEF 306663
7 XBRL LABEL FILE nphc-20211231_lab.xml EX-101.LAB 516535
8 XBRL PRESENTATION FILE nphc-20211231_pre.xml EX-101.PRE 414407
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1368604
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32141 | Film No.: 22829456
SIC: 2833 Medicinal Chemicals & Botanical Products